Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
266 studies found for:    Open Studies | "Edema"
Show Display Options
Rank Status Study
21 Unknown  Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Conditions: Diabetic Macular Edema.;   Non-proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Interventions: Drug: dexamethasone intravitreal implant;   Drug: intravitreal bevacizumab
22 Unknown  OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Conditions: Diabetes;   Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Device: OCT imaging
23 Recruiting Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
Conditions: Acute Respiratory Distress Syndrome (ARDS);   Hypovolemia;   Pulmonary Edema
Intervention: Drug: 4% albumin
24 Not yet recruiting Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
Condition: Macular Edema
Intervention: Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
25 Unknown  Mortality and Risk Factors in Patients With Acute Cardiogenic Pulmonary Edema: a Multicentric, Observational, Prospective Study
Conditions: Pulmonary Edema;   Respiratory Insufficiency
Intervention: Device: Non invasive ventilation
26 Unknown  Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
Conditions: Retinal Vein Occlusion;   Macular Edema
Interventions: Drug: ranibizumab;   Radiation: Argon laser treatment
27 Recruiting Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
Conditions: Visual Acuity Reduced Transiently;   Macular Edema, Cystoid
Intervention: Drug: ranibizumab
28 Unknown  Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Device: Micropulse laser treatment;   Device: Laser modified ETDRS
29 Unknown  Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Intervention: Drug: Intravitreal injection (triamcinolone acetonide)
30 Unknown  Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Infliximab (intravitreal, 2.0mg/0.05ml)
31 Unknown  Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: dexamethasone - Cyclodextrin eye drops;   Other: intravitreal Avastin injection +/- macular laser
32 Recruiting Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Interventions: Drug: Ranibizumab,;   Drug: Triamcinolone acetonide
33 Recruiting Sub-threshold Photocoagulation of Diabetic Macular Oedema
Condition: Diabetic Macular Oedema
Interventions: Device: PASCAL Laser, Green Laser 0.75;   Device: PASCAL Laser, Green Laser 1;   Device: PASCAL Laser, 70% Yellow Laser 0.75;   Device: PASCAL Laser, 70% Yellow Laser 1;   Device: PASCAL Laser, 40% Yellow Laser 0.75;   Device: PASCAL Laser, 40% Yellow Laser 1
34 Unknown  Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Ranibizumab
35 Recruiting Phase I/II Trial to Find Maximum Tolerated Dose (MTD) and Dose Limiting Toxicities (DLT) of TLC399 (ProDex) in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
Conditions: Central Retinal Vein Occlusion With Macular Edema;   Branch Retinal Vein Occlusion With Macular Edema
Intervention: Drug: TLC399(ProDex)
36 Recruiting Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema
Conditions: Diabetic Macular Oedema;   Parafoveal Scotoma
Interventions: Other: Temporal Group;   Other: Spatial Group;   Other: Combined Group;   Other: Control Group
37 Recruiting Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: aflibercept
38 Recruiting Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide
Condition: Diabetic Macular Edema
Intervention: Drug: Triamcinolone Acetonide
39 Recruiting Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab
40 Recruiting Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Ranibizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years